Bioscience Group Warns Policymakers Against C...(ite them to experience first hand what b...)

Date:1/10/2008

ite them to experience first hand what businesses in the life sciences industry do. Findings from BayBio:IMPACT 2008 will be released at launch events starting today in San Francisco and following in Sacramento and Washington D.C. Industry representatives and policymakers will be in attendance with keynote speeches from leading biotech executives.

About BayBio

As the life sciences association in Northern California, BayBio serves the region's 1,377 life sciences companies, as well as research institutes, universities and public officials at all levels of government that are engaged in or supportive of research, development and commercialization of life science products. BayBio supports the regional life sciences community through advocacy, education and networking about the impact of the biotech industry on the community.

Built by the founders of biotechnology, BayBio was established in 1990 by a consortium of universities, public officials, educators and bioscience executives to foster a regional climate that nourishes the bioscience life cycle. In 2006, BayBio divided its activities into two organizations: BayBio and the BayBio Institute. BayBio focuses on improvement of business conditions in the industry and advocacy as a trade association, and the BayBio Institute focuses on life science educational efforts in Northern California. For more information about BayBio or to view the BayBio:IMPACT 2008 study, visit http://www.baybio.org.

'/>"/>

SOURCE BayBio Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
2. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB COLORECTAL CANCER TRIAL FIRST COHORT IS CLOSED TO ACCRUAL
3. Ardea Biosciences Announces $40 Million Private Placement
4. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
5. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
6. Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
7. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
8. Sangamo BioSciences to Present at the BMO Capital Markets Health Care Conference
9. BioSpace Launches 3rd Edition of BioForest(TM) Bioscience Marketing Campaign
10. Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
11. Schering-Plough Completes Acquisition of Organon BioSciences